ES2421885T3 - Polipéptidos y procedimiento para la detección específica de anticuerpos en pacientes con una infección por Borrelia - Google Patents

Polipéptidos y procedimiento para la detección específica de anticuerpos en pacientes con una infección por Borrelia

Info

Publication number
ES2421885T3
ES2421885T3 ES08021660T ES08021660T ES2421885T3 ES 2421885 T3 ES2421885 T3 ES 2421885T3 ES 08021660 T ES08021660 T ES 08021660T ES 08021660 T ES08021660 T ES 08021660T ES 2421885 T3 ES2421885 T3 ES 2421885T3
Authority
ES
Spain
Prior art keywords
polypeptides
antibodies
patients
procedure
specific detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES08021660T
Other languages
English (en)
Inventor
Lars Komorowski
Christian Probst
Anthonina Janssen
Winfried Stoecker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euroimmun Medizinische Labordiagnostika AG
Original Assignee
Euroimmun Medizinische Labordiagnostika AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40568393&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2421885(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Euroimmun Medizinische Labordiagnostika AG filed Critical Euroimmun Medizinische Labordiagnostika AG
Application granted granted Critical
Publication of ES2421885T3 publication Critical patent/ES2421885T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/20Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/20Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Proteína que comprende un primer polipéptido de OspC, caracterizada porque el primer polipéptido de OspC está unidoa través de un puente disulfuro con un segundo polipéptido de OspC, formándose el puente disulfuro por unión de unacisteína que no está alejada más de 100 posiciones de aminoácidos del extremo N-terminal del polipéptido de OspC,presentando el primer y el segundo polipéptido de OspC una identidad de aminoácidos de al menos el 70% con la SEC IDNº: 3, SEC ID Nº: 6 o SEC ID Nº: 9.
ES08021660T 2008-12-12 2008-12-12 Polipéptidos y procedimiento para la detección específica de anticuerpos en pacientes con una infección por Borrelia Active ES2421885T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08021660.9A EP2199303B1 (de) 2008-12-12 2008-12-12 Polypeptide und Verfahren zur spezifischen Detektion von Antikörpern bei Patienten mit einer Borrelieninfektion

Publications (1)

Publication Number Publication Date
ES2421885T3 true ES2421885T3 (es) 2013-09-06

Family

ID=40568393

Family Applications (1)

Application Number Title Priority Date Filing Date
ES08021660T Active ES2421885T3 (es) 2008-12-12 2008-12-12 Polipéptidos y procedimiento para la detección específica de anticuerpos en pacientes con una infección por Borrelia

Country Status (4)

Country Link
US (2) US8163500B2 (es)
EP (1) EP2199303B1 (es)
ES (1) ES2421885T3 (es)
PL (1) PL2199303T3 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2959971A1 (de) 2014-06-27 2015-12-30 Euroimmun Medizinische Labordiagnostika AG Verfahren und Vorrichtung zur Überführung von Flüssigkeiten
US11061028B2 (en) 2014-09-24 2021-07-13 Defined Diagnostics, Llc Compositions and methods for the diagnosis of lyme disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991009870A1 (de) 1989-12-22 1991-07-11 Mikrogen Molekularbiologische Entwicklungs-Gmbh Immunologisch aktive proteine von borrelia burgdorferi, zusammenhängende testkits und impfstoff
US5620862A (en) * 1993-11-24 1997-04-15 University Of Connecticut Methods for diagnosing early Lyme disease
EP1741718A3 (en) 1995-06-07 2007-03-28 Sanofi Pasteur Inc. Expression of lipoproteins
ATE232212T1 (de) 1996-05-02 2003-02-15 Dako As Verwendung von aus osp-c abgeleiteten peptidefragmenten für diagnostische methoden
AT405940B (de) * 1996-06-21 1999-12-27 Immuno Ag Verfahren zur gewinnung und reinigung von rekombinantem, nicht-lipidiertem osp-protein

Also Published As

Publication number Publication date
PL2199303T3 (pl) 2013-11-29
US20100150964A1 (en) 2010-06-17
US8431135B2 (en) 2013-04-30
EP2199303B1 (de) 2013-06-05
US20120177680A1 (en) 2012-07-12
US8163500B2 (en) 2012-04-24
EP2199303A1 (de) 2010-06-23

Similar Documents

Publication Publication Date Title
AR123908A2 (es) Proteínas de fusión para tratar trastorno metabólicos
ES2545895T3 (es) Proteína de fusión anticancerígena
EA201100070A1 (ru) Туберкулезный белок rv2386c, композиции и их применения
NO20063026L (no) Antistoffer
PE20190352A1 (es) Proteinas de fusion gdf 15 y usos de estas
EA201491049A1 (ru) Противораковый слитый белок
PE20100054A1 (es) Inmunoglobulina con dominio variable dual
ES2531288T3 (es) Proteína de fusión anticancerígena
PE20120532A1 (es) ANTICUERPOS ANTI-ActRIIB
GEP20115333B (en) Antagonist antibodies directed against calcitonin generelated peptide and using same
PE20120021A1 (es) Mutantes fgf21
WO2007115837B1 (en) Combination of an anti-edb fibronectin domain antibody/ il2 fusion protein and a further small molecule
EA201100071A1 (ru) Новые композиции и способы
PE20120170A1 (es) Variantes de union a anti-albumina de suero mejoradas
UA107330C2 (uk) Туберкульозний білок rv3616c та його застосування
DK1576967T3 (da) Rekombinant protein, der bærer epitoper fra det humane papillomvirus indsat i et adenylatcyclaseprotein eller et fragment deraf samt dets terapeutiske anvendelse
EA201491277A1 (ru) Противораковый слитый белок
UA108778C2 (xx) Протираковий злитий протеїн
MX340772B (es) Medios y metodos para fabricar neurotoxina altamente pura.
ES2531115T3 (es) Combinaciones de clados de RrgB neumocócicos
BR112013025975A2 (pt) proteína de fusão anticancerígena
WO2008105178A1 (ja) リポソーム用生体成分抵抗性増強剤及びこれにより修飾されたリポソーム
MX2010010213A (es) Peptido parcial de lacritina.
ES2421885T3 (es) Polipéptidos y procedimiento para la detección específica de anticuerpos en pacientes con una infección por Borrelia
NZ591133A (en) Novel melanoma antigen peptide and uses thereof